Cardioembolic Stroke in Patients with Patent Foramen Ovale and Implanted Cardiac Leads
Article first published online: 18 OCT 2012
©2012, The Authors. Journal compilation ©2012 Wiley Periodicals, Inc.
Pacing and Clinical Electrophysiology
Volume 36, Issue 1, pages 50–54, January 2013
How to Cite
DESIMONE, C. V., DESIMONE, D. C., HAGLER, D. J., FRIEDMAN, P. A. and ASIRVATHAM, S. J. (2013), Cardioembolic Stroke in Patients with Patent Foramen Ovale and Implanted Cardiac Leads. Pacing and Clinical Electrophysiology, 36: 50–54. doi: 10.1111/pace.12014
- Issue published online: 9 JAN 2013
- Article first published online: 18 OCT 2012
- Manuscript Accepted: 14 AUG 2012
- Manuscript Revised: 26 JUL 2012
- Manuscript Received: 21 MAY 2012
- 1Implantation of cardiac resynchronization devices. In: St. John Sutton M, Bax J, Jessup M, Brugada J, Schalij MJ (eds.): Cardiac Resynchronization Therapy. London, Informa Healthcare, 2007..
- 3Clinical significance of debris on pacemaker leads detected by transesophageal echocardiography (abstract). Europace 2000; 1:D239., et al.
- 9Extraction of implantable cardiac electronic devices. Curr Cardiol Rep 2011; 13:407–414., .
- 10Study design of the CLOSURE I Trial: A prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale. Stroke 2010; 41:2872–2883., , , , , , , et al.